$322 Million is the total value of Eversept Partners, LP's 57 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 53.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GSK | Buy | GLAXOSMITHKLINE PLCsponsored adr | $42,337,144 | +50.7% | 983,085 | +41.7% | 13.13% | +67.0% |
| ENSG | Buy | ENSIGN GROUP INC | $27,849,345 | +60.0% | 586,674 | +92.0% | 8.64% | +77.3% |
| DHR | Buy | DANAHER CORPORATION | $25,838,590 | +24.5% | 178,704 | +23.2% | 8.02% | +37.9% |
| ZGNX | Buy | ZOGENIX INC | $25,778,473 | +0.5% | 643,818 | +19.9% | 8.00% | +11.3% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $22,769,277 | +45.0% | 236,392 | +73.3% | 7.06% | +60.6% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $20,158,176 | -33.3% | 1,329,695 | -14.7% | 6.25% | -26.1% |
| SNY | Sell | SANOFIsponsored adr | $11,119,200 | -3.4% | 240,000 | -9.8% | 3.45% | +7.0% |
| RDUS | Sell | RADIUS HEALTH INC | $8,875,974 | -48.7% | 344,698 | -51.5% | 2.75% | -43.2% |
| NVST | New | ENVISTA HLDGS CORP | $8,865,840 | – | 318,000 | +100.0% | 2.75% | – |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $8,625,003 | -18.7% | 50,909 | -12.0% | 2.68% | -9.9% |
| ILMN | Buy | ILLUMINA INC | $8,137,885 | +20.9% | 26,750 | +46.3% | 2.52% | +33.9% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $7,401,857 | +17.1% | 92,040 | +5.6% | 2.30% | +29.6% |
| BOLD | Buy | AUDENTES THERAPEUTICS INC | $7,127,163 | +18.0% | 253,726 | +59.0% | 2.21% | +30.8% |
| DXCM | New | DEXCOM INC | $6,648,642 | – | 44,550 | +100.0% | 2.06% | – |
| RCM | Sell | R1 RCM INC | $6,482,930 | -80.9% | 725,972 | -73.1% | 2.01% | -78.8% |
| ABMD | New | ABIOMED INC | $5,327,806 | – | 29,950 | +100.0% | 1.65% | – |
| OHI | Buy | OMEGA HEALTHCARE INVS INC | $4,450,635 | +192.5% | 106,500 | +157.2% | 1.38% | +224.2% |
| TGTX | Sell | TG THERAPEUTICS INC | $4,343,208 | -43.2% | 773,501 | -12.5% | 1.35% | -37.1% |
| OXFD | New | OXFORD IMMUNOTEC GLOBAL PLC | $4,257,280 | – | 256,000 | +100.0% | 1.32% | – |
| TLGT | Buy | TELIGENT INC NEW | $4,202,126 | +158.0% | 4,424,222 | +71.2% | 1.30% | +186.0% |
| ARGX | Sell | ARGENX SEsponsored adr | $4,103,016 | -40.0% | 36,004 | -25.4% | 1.27% | -33.5% |
| LTC | Buy | LTC PPTYS INC | $3,550,929 | +135.5% | 69,327 | +109.9% | 1.10% | +161.1% |
| SBRA | Buy | SABRA HEALTH CARE REIT INC | $3,538,136 | +128.6% | 154,100 | +96.1% | 1.10% | +153.6% |
| MODN | New | MODEL N INC | $3,350,493 | – | 120,695 | +100.0% | 1.04% | – |
| CTRE | Buy | CARETRUST REIT INC | $3,259,950 | +117.5% | 137,464 | +120.1% | 1.01% | +140.7% |
| BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $2,980,764 | +79.9% | 708,020 | +98.7% | 0.92% | +99.4% |
| ARQL | Sell | ARQULE INC | $2,956,822 | -40.5% | 412,388 | -8.7% | 0.92% | -34.2% |
| HSKA | Buy | HESKA CORP | $2,893,197 | -2.7% | 40,824 | +16.9% | 0.90% | +7.8% |
| EHTH | Sell | EHEALTH INC | $2,848,794 | -81.5% | 42,653 | -76.1% | 0.88% | -79.5% |
| AMRN | New | AMARIN CORP PLCcall | $2,442,276 | – | 161,100 | +100.0% | 0.76% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $2,184,388 | -50.6% | 140,656 | -35.4% | 0.68% | -45.2% |
| CYH | New | COMMUNITY HEALTH SYS INC NEW | $2,186,579 | – | 607,383 | +100.0% | 0.68% | – |
| CYTK | New | CYTOKINETICS INC | $2,067,746 | – | 181,700 | +100.0% | 0.64% | – |
| TCDA | Sell | TRICIDA INC | $2,024,084 | -41.4% | 65,568 | -25.1% | 0.63% | -35.1% |
| MGNX | Sell | MACROGENICS INC | $1,975,554 | -38.9% | 154,824 | -18.8% | 0.61% | -32.3% |
| XENE | Sell | XENON PHARMACEUTICALS INC | $1,942,637 | -12.2% | 215,609 | -3.9% | 0.60% | -2.6% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $1,915,372 | -35.6% | 79,509 | -32.2% | 0.59% | -28.6% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS | $1,875,028 | +44.5% | 654,460 | +91.1% | 0.58% | +60.3% |
| COLL | Buy | COLLEGIUM PHARMACEUTICAL INC | $1,840,187 | -0.8% | 160,295 | +13.7% | 0.57% | +10.0% |
| SCPH | Buy | SCPHARMACEUTICALS INC | $1,301,003 | +134.0% | 221,636 | +27.2% | 0.40% | +159.0% |
| AGRX | New | AGILE THERAPEUTICS INC | $1,077,740 | – | 909,485 | +100.0% | 0.33% | – |
| IVC | Sell | INVACARE CORP | $970,208 | -11.1% | 129,361 | -38.5% | 0.30% | -1.6% |
| AFMD | AFFIMED N V | $947,183 | +2.4% | 322,171 | 0.0% | 0.29% | +13.5% | |
| OTIC | Buy | OTONOMY INC | $899,457 | +68.2% | 376,342 | +93.6% | 0.28% | +86.0% |
| CDXS | New | CODEXIS INC | $864,045 | – | 63,000 | +100.0% | 0.27% | – |
| SVRA | Buy | SAVARA INC | $839,199 | +46.2% | 316,679 | +30.8% | 0.26% | +61.5% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $746,680 | -89.2% | 22,000 | -92.8% | 0.23% | -88.0% |
| OPTN | OPTINOSE INC | $735,742 | -1.1% | 105,106 | 0.0% | 0.23% | +9.6% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $714,507 | -3.3% | 69,708 | 0.0% | 0.22% | +7.2% | |
| DRNA | DICERNA PHARMACEUTICALS INC | $589,823 | -8.8% | 41,074 | 0.0% | 0.18% | +1.1% | |
| NLNK | New | NEWLINK GENETICS CORP | $434,043 | – | 272,983 | +100.0% | 0.14% | – |
| PFNX | Sell | PFENEX INC | $404,850 | -25.8% | 47,968 | -40.8% | 0.13% | -17.6% |
| CVM | New | CEL SCI CORPput | $382,632 | – | 42,800 | +100.0% | 0.12% | – |
| ALBO | ALBIREO PHARMA INC | $360,580 | -38.0% | 18,029 | 0.0% | 0.11% | -31.3% | |
| AIMT | New | AIMMUNE THERAPEUTICS INCput | $209,400 | – | 10,000 | +100.0% | 0.06% | – |
| AIMT | New | AIMMUNE THERAPEUTICS INCcall | $190,554 | – | 9,100 | +100.0% | 0.06% | – |
| AKRXQ | Sell | AKORN INC | $152,920 | -77.4% | 40,242 | -69.4% | 0.05% | -75.3% |
| AQXP | Exit | AQUINOX PHARMACEUTICALS INC | $0 | – | -73,717 | -100.0% | -0.05% | – |
| CYCN | Exit | CYCLERION THERAPEUTICS INC | $0 | – | -18,925 | -100.0% | -0.06% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALScall | $0 | – | -101,800 | -100.0% | -0.11% | – |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -84,296 | -100.0% | -0.17% | – |
| FOMX | Exit | FOAMIX PHARMACEUTICALS LTD | $0 | – | -263,390 | -100.0% | -0.18% | – |
| PRVB | Exit | PROVENTION BIO INC | $0 | – | -73,661 | -100.0% | -0.25% | – |
| ZGNX | Exit | ZOGENIX INCput | $0 | – | -36,400 | -100.0% | -0.49% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -57,200 | -100.0% | -0.58% | – |
| PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -48,600 | -100.0% | -0.61% | – |
| GHDX | Exit | GENOMIC HEALTH INC | $0 | – | -38,403 | -100.0% | -0.63% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -16,554 | -100.0% | -0.70% | – |
| HUM | Exit | HUMANA INC | $0 | – | -10,000 | -100.0% | -0.74% | – |
| ANTM | Exit | ANTHEM INC | $0 | – | -10,000 | -100.0% | -0.79% | – |
| MYOK | Exit | MYOKARDIA INC | $0 | – | -56,652 | -100.0% | -0.80% | – |
| DERM | Exit | DERMIRA INC | $0 | – | -399,874 | -100.0% | -1.07% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -73,501 | -100.0% | -1.21% | – |
| ZGNX | Exit | ZOGENIX INCcall | $0 | – | -104,300 | -100.0% | -1.40% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -99,600 | -100.0% | -1.46% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -91,798 | -100.0% | -1.50% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-11-08
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.